Full-Time

Vice President

Clinical Effectiveness

Posted on 8/24/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$184.2k - $307k/yr

Madison, WI, USA + 12 more

More locations: Boston, MA, USA | Indianapolis, IN, USA | Augusta, ME, USA | East Lansing, MI, USA | Annapolis, MD, USA | Tallahassee, FL, USA | Trenton, NJ, USA | Highland Park, IL, USA | Albany, NY, USA | Hartford, CT, USA | Springfield, IL, USA | St Paul, MN, USA

Hybrid

Category
Medical, Clinical & Veterinary (1)
Required Skills
Data Analysis
Requirements
  • Ten years of progressive healthcare delivery leadership experience with direct oversight of clinical transformation, quality performance and/or patient outcomes improvement (Licensed Clinician preferred)
  • Proven experience developing and scaling clinical transformation
  • At least five (5) years senior leadership experience in VP or higher role in fast paced dynamic environment
  • Five (5) years health informatics experience (preferred)
  • Master’s degree required; advanced degree preferred (PhD, DNP, etc.)
  • Solid understanding of the healthcare landscape, current trends, competitive forces, and regulations impacting the marketplace
  • Proven transformative leadership experience developing strategic quality, safety, and patient outcome improvement initiatives which align with business goals, timelines and budget
  • Ability to translate clinical and professional service opportunities into tangible revenue growth and value
  • Proven change management leadership experience related to quality, safety, and improved patient outcomes
  • Excellent communication, presentation, and organizational skills; demonstrated flexibility and ability to work with and engage all levels of an organization
  • Proven experience collaborating with internal and external resources to develop strategies that meet organization goals
  • Proficiency in identifying operational issues, recommending, and implementing strategies to resolve problems inclusive of short-term tactical actions and long-term strategic plans
  • Successful history of implementing large, national scale projects with ability to structure, format and lead small to large multi-disciplinary project teams to achieve objectives; proven ability to keep projects on track and moving towards goals
  • Proficient influencing skills with established success garnering support of executive level decision-makers and front line staff
  • Exceptional analytic skills. Demonstrated quantitative skills
  • Demonstrated financial acumen; experience leading revenue generating teams and managing a P&L preferred
Responsibilities
  • Develops insights and strategies to enhance, expand and/or create clinical processes and service offerings by leveraging core business platforms and service models, patient outcomes information and industry data with objective to deliver superior patient outcomes and support business growth while maintaining high levels of quality of care
  • Leads and oversees design and implementation of programs in collaboration with internal stakeholder leadership
  • Identifies and sets metrics of success and other key performance indicators (KPIs)
  • Actively manages KPIs to ensure desired results are achieved, addressing barriers, and making process adjustments as needed through the process
  • Oversees the analysis of OCH’s patient populations, performance, and service offerings and/or other existing data from multiple internal and external sources to inform quality improvement and patient outcomes objectives, establish value and measure success of OCH’s clinical service offerings
  • Leads teams in evaluating, developing, and recommending clinical workflow processes to enhance quality of care, patient outcomes, access to care, stakeholder satisfaction, and/or lower cost of care
  • Recommends and implements evidenced based practices
  • Processes and synthesizes program outputs into executive level presentations, updates, risk mitigation plans and business recommendations with ability to facilitate group discussions and debate with the ability to influence and communicate effectively across functional lines and levels
  • Contributes to clinical procedures and standards including introduction of 'best practices', necessary competencies and skills to improve outcomes and maintain high quality of care, improve efficiency, and in consideration of clinician satisfaction
  • Champions change, innovation and continuous cycles of improvement while maintaining strong relationships and alignment with business partners and stakeholders
  • Maintains focus on using technology to create efficiencies and evidenced based findings
  • Monitors organizational outcomes against external comparative databases, evidence-based knowledge, and industry best practice
  • Develops and executes immediate, near term and long-term initiatives in response to trends and outcomes
  • Advises leadership on trends and progress on associated responsive plans
  • Support and adherence to organizational data governance procedures; ensure alignment on use and disclosure of data and establishes processes as needed for new and/or revised initiatives
  • Chairs and/or serves on OCH Committees which support evaluation of new products, therapies, and service offerings and which assess expansion of clinical offerings and/or business growth including but not limited to the Clinical Review Board, Clinical Trials Committee, Academic Research Committee
  • Develops and mentors staff through on-boarding, open communication, training and development opportunities and performance management processes; builds and maintains employee morale and motivation, fosters a diverse and inclusive workplace
Desired Qualifications
  • Participation in professional organizations related to healthcare, risk management or quality management

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE